Ontology highlight
ABSTRACT: Background
Acute Myeloid Leukemia (AML) is characterized by various cytogenetic and molecular abnormalities. Detection of these abnormalities is important in the risk-classification of patients but requires laborious experimentation. Various studies showed that gene expression profiles (GEP), and the gene signatures derived from GEP, can be used for the prediction of subtypes in AML. Similarly, successful prediction was also achieved by exploiting DNA-methylation profiles (DMP). There are, however, no studies that compared classification accuracy and performance between GEP and DMP, neither are there studies that integrated both types of data to determine whether predictive power can be improved.Approach
Here, we used 344 well-characterized AML samples for which both gene e
SUBMITTER: Taskesen E
PROVIDER: S-EPMC4347619 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature